Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 4/20 | 0.56 |
| ▸ | MEN1 | O00255 | 1/20 | 0.56 |
| ▸ | ABL1 | P00519 | 1/20 | 0.56 |
| ▸ | LMNA | P02545 | 1/20 | 0.56 |
| ▸ | PKM | P14618 | 1/20 | 0.56 |
| ▸ | IDE | P14735 | 1/20 | 0.56 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.56 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.56 |
| ▸ | RIN1 | Q13671 | 1/20 | 0.56 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.56 |
| ▸ | FNTA | P49354 | 13/20 | 0.50 |
| ▸ | FNTB | P49356 | 11/20 | 0.50 |
| ▸ | PGGT1B | P53609 | 6/20 | 0.50 |
| ▸ | PLCD1 | P51178 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19350969 | 0.87 | PLCD1 (0.51) | TDP1MEN1ABL1LMNAPKM | |
| Ammonia Solution, Strong SCHEMBL29662377 | 0.86 | PLCD1 (0.50) | TDP1MEN1ABL1LMNAPKM | |
| Biotin SCHEMBL7845644 | 0.83 | TDP1 (0.77) | TDP1MEN1ABL1LMNAPKM | |
| Biotin SCHEMBL31222652 | 0.77 | TDP1 (0.90) | TDP1MEN1ABL1LMNAPKM | |
| Biotin SCHEMBL8039828 | 0.76 | TDP1 (0.92) | TDP1MEN1ABL1LMNAPKM | |
| Biotin SCHEMBL20641180 | 0.75 | TDP1 (0.85) | TDP1MEN1ABL1LMNAPKM | |
| Biotin SCHEMBL17275255 | 0.75 | TDP1 (0.85) | TDP1MEN1ABL1LMNAPKM | |
| Biotin SCHEMBL4799681 | 0.75 | TDP1 (0.55) | TDP1MEN1ABL1LMNAPKM | |
| Biotin SCHEMBL2009698 | 0.75 | TDP1 (0.55) | TDP1MEN1ABL1LMNAPKM | |
| Biotin SCHEMBL27730062 | 0.75 | TDP1 (0.90) | TDP1MEN1ABL1LMNAPKM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220380831-A1 | PRENYLATION ASSAY | OXFORD UNIVERSITY INNOVATION LIMITED (GB) | 2022-12-01 | — | — | US | claimed |
| EP-3426795-B1 | PRENYLATION ASSAY | NIGHTSTARX LTD (GB) | 2021-01-27 | — | — | EP | claimed |
| US-20200341015-A1 | PRENYLATION ASSAY | NIGHTSTARX LTD. (GB) | 2020-10-29 | — | — | US | claimed |
| EP-3697923-A1 | PRENYLATION ASSAY | Nightstarx Limited (GB) | 2020-08-26 | — | — | EP | claimed |
| WO-2019079488-A1 | PRENYLATION ASSAY | NIGHTSTARX LIMITED (GB) | 2019-04-25 | — | — | WO | claimed |
| US-20190017096-A1 | PRENYLATION ASSAY | OXFORD UNIVERSITY INNOVATION LIMITED (GB) | 2019-01-17 | — | — | US | claimed |
| US-20220380831-A1 | PRENYLATION ASSAY | OXFORD UNIVERSITY INNOVATION LIMITED (GB) | 2022-12-01 | — | — | US | disclosed |
| WO-2022109247-A1 | VIRAL VECTOR POTENCY ASSAY | BIOGEN MA INC. (US) | 2022-05-27 | — | — | WO | disclosed |
| EP-3426795-B1 | PRENYLATION ASSAY | NIGHTSTARX LTD (GB) | 2021-01-27 | — | — | EP | disclosed |
| US-20200341015-A1 | PRENYLATION ASSAY | NIGHTSTARX LTD. (GB) | 2020-10-29 | — | — | US | disclosed |
| EP-3697923-A1 | PRENYLATION ASSAY | Nightstarx Limited (GB) | 2020-08-26 | — | — | EP | disclosed |
| WO-2019079488-A1 | PRENYLATION ASSAY | NIGHTSTARX LIMITED (GB) | 2019-04-25 | — | — | WO | disclosed |
| US-20190017096-A1 | PRENYLATION ASSAY | OXFORD UNIVERSITY INNOVATION LIMITED (GB) | 2019-01-17 | — | — | US | disclosed |
| EP-3426795-A1 | PRENYLATION ASSAY | Nightstarx Limited (GB) | 2019-01-16 | — | — | EP | disclosed |
| WO-2017153774-A1 | PRENYLATION ASSAY | NIGHTSTARX LIMITED (GB) | 2017-09-14 | — | — | WO | disclosed |